AUTL — Autolus Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.09bn
- $379.73m
- $1.70m
- 37
- 10
- 65
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -124 | -142 | -142 | -149 | -208 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 34.4 | 18.6 | 11.7 | 25.4 | 56.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -16.2 | 1.41 | 4.14 | 3.97 | 0.292 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -101 | -118 | -118 | -112 | -146 |
Capital Expenditures | -18.7 | -14.7 | -8.86 | -10.8 | -11 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -18.7 | -14.7 | -8.86 | -10.8 | -11 |
Financing Cash Flow Items | — | — | 38 | 59.6 | -0.91 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 109 | 74.4 | 284 | 224 | -0.883 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6.13 | -57.3 | 157 | 72.1 | -142 |